Pharmaceutical Executive February 28, 2024
The device can detect potential warning signs of serious conditions.
Reese Pharmaceutical is launching a new at home colon cancer screening test as part of its diagnostic portfolio. The over-the-counter test is FDA approved and is available now.
According to a press release,1 the test is a fecal immunochemical test and is able to detect blood in the stool, even if it is not visible to the naked eye. This can be used as an early warning sign of colon cancer, along with other conditions like diverticulitis and polyps. The test has a suggested retail price of $19.99.
In a press release, Reese Pharmaceutical’s president Jeffrey Reese said, “90% of colon cancer-related deaths are thought to be preventable if caught...